K., Krarup, T., Vlund, A., Holst, J
Semaglutide reduces A1C by approximately 1.5% to 1.8% while producing significant weight loss
As the half-life of retatrutide is 6 days, once weekly administration was sufficient with as expected gastrointestinal disturbance being the most common side effect and occurring in 63% of those on retatrutide, 60% on dulaglutide, and 54% of the placebo cohort [63]
Illustrative GLP - 1 US adult adoption curve 10-year horizon 1 While usage for diabetes will continue to grow, the far larger growth driver will be users without a type 2 diabetes diagnosis who are focused on weight loss
Not only does it help with weight loss, but it also tightens my skin, and it feels amazing